170 related articles for article (PubMed ID: 23496911)
1. Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk.
Mao Y; Xu X; Lin Y; Chen H; Wu J; Hu Z; Zhu Y; Xu X; Xie L
World J Surg Oncol; 2013 Mar; 11():58. PubMed ID: 23496911
[TBL] [Abstract][Full Text] [Related]
2. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
3. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
Li Y; Liu F; Tan SQ; Wang Y; Li SW
PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
[TBL] [Abstract][Full Text] [Related]
4. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
5. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
[TBL] [Abstract][Full Text] [Related]
6. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.
Xue H; Ni P; Lin B; Xu H; Huang G
Am J Epidemiol; 2011 Feb; 173(4):363-75. PubMed ID: 21216841
[TBL] [Abstract][Full Text] [Related]
7. XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis.
Zhang F; Wu JH; Zhao W; Liu HT
Tumour Biol; 2013 Oct; 34(5):2659-64. PubMed ID: 23636799
[TBL] [Abstract][Full Text] [Related]
8. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
[TBL] [Abstract][Full Text] [Related]
9. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.
Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G
PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969
[TBL] [Abstract][Full Text] [Related]
10. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of an association between the XRCC1 polymorphisms and gliomas risk.
Li M; Zhou Q; Tu C; Jiang Y
J Neurooncol; 2013 Feb; 111(3):221-8. PubMed ID: 23238971
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
Zhang H; Liu H; Jiang G
PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.
Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C
Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970
[TBL] [Abstract][Full Text] [Related]
14. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
[TBL] [Abstract][Full Text] [Related]
15. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
Wei B; Zhou Y; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):225-31. PubMed ID: 21647176
[TBL] [Abstract][Full Text] [Related]
16. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
Li C; Xiang X; Zhou Y
Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624
[TBL] [Abstract][Full Text] [Related]
17. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta- Analysis Study.
Sanjari Moghaddam A; Nazarzadeh M; Sanjari Moghaddam H; Bidel Z; Keramatinia A; Darvish H; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2016; 17(S3):323-30. PubMed ID: 27165246
[TBL] [Abstract][Full Text] [Related]
19. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
[TBL] [Abstract][Full Text] [Related]
20. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
Zhang H; Liu H; Knauss JL
Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
